186 related articles for article (PubMed ID: 26316700)
1. RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.
Feng C; Li X; Dong C; Zhang X; Zhang X; Gao Y
Drug Des Devel Ther; 2015; 9():4613-20. PubMed ID: 26316700
[TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid.
Wang J; Maitani Y; Takayama K
J Pharm Sci; 2002 Apr; 91(4):1128-34. PubMed ID: 11948551
[TBL] [Abstract][Full Text] [Related]
4. PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting.
Su W; Wang H; Wang S; Liao Z; Kang S; Peng Y; Han L; Chang J
Int J Pharm; 2012 Apr; 426(1-2):170-181. PubMed ID: 22266537
[TBL] [Abstract][Full Text] [Related]
5. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
[TBL] [Abstract][Full Text] [Related]
6. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
7. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo.
Shiokawa T; Hattori Y; Kawano K; Ohguchi Y; Kawakami H; Toma K; Maitani Y
Clin Cancer Res; 2005 Mar; 11(5):2018-25. PubMed ID: 15756028
[TBL] [Abstract][Full Text] [Related]
8. Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles.
Jia Y; Ji J; Wang F; Shi L; Yu J; Wang D
Drug Deliv; 2016 May; 23(4):1317-25. PubMed ID: 25371296
[TBL] [Abstract][Full Text] [Related]
9. Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor.
Gao H; Wang JY; Shen XZ; Deng YH; Zhang W
World J Gastroenterol; 2004 Jul; 10(14):2010-3. PubMed ID: 15237424
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
[TBL] [Abstract][Full Text] [Related]
11. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
Yang Y; Xie X; Yang Y; Zhang H; Mei X
J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
[TBL] [Abstract][Full Text] [Related]
13. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer.
Hu Y; Zhang J; Hu H; Xu S; Xu L; Chen E
Cell Cycle; 2020 Dec; 19(24):3581-3594. PubMed ID: 33300430
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro and in vivo antitumor effects of gambogic acid-loaded layer-by-layer self-assembled micelles.
Ke Z; Yang L; Wu H; Li Z; Jia X; Zhang Z
Int J Pharm; 2018 Jul; 545(1-2):306-317. PubMed ID: 29654896
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
17. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
[TBL] [Abstract][Full Text] [Related]
18. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.
Cai W; Geng C; Jiang L; Sun J; Chen B; Zhou Y; Yang B; Lu H
Pharm Dev Technol; 2020 Jun; 25(5):640-648. PubMed ID: 32028816
[TBL] [Abstract][Full Text] [Related]
20. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]